Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4776
CALL
Li Auto
LI
$14.4B
| $27.9K | ﹤0.01% |
+1,100
| New | +$28.5K |
|
4777
Adecoagro
AGRO
$1.4B
| $27.7K | ﹤0.01% |
3,532
-1,267
| -26% | -$11.1K |
|
4778
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$413M
| $27.6K | ﹤0.01% |
300
| – | – |
|
4779
CALL
SoundHound AI
SOUN
$2.48B
| $27.3K | ﹤0.01% |
+1,700
| New | +$22.6K |
|
4780
Seres Therapeutics
MCRB
$45M
| $27.1K | ﹤0.01% |
+1,408
| New | +$22.5K |
|
4781
CALL
Kroger
KR
$36.7B
| $27K | ﹤0.01% |
400
-346,000
| -100% | -$24.1M |
|
4782
Karyopharm Therapeutics
KPTI
$155M
| $26.9K | ﹤0.01% |
4,109
-1,224
| -23% | -$6.58K |
|
4783
Lipocine
LPCN
$17.1M
| $26.8K | ﹤0.01% |
9,412
| – | – |
|
4784
CALL
Rigetti Computing
RGTI
$4.39B
| $26.8K | ﹤0.01% |
+900
| New | +$15.8K |
|
|
VBNK
4785
VersaBank
VBNK
$623M
| $26.7K | ﹤0.01% |
2,190
-593
| -21% | -$6.85K |
|
|
PPLT
4786
abrdn Physical Platinum Shares ETF
PPLT
$1.83B
| $26.7K | ﹤0.01% |
1,870
-1,329,630
| -100% | -$16.8M |
|
4787
Werewolf Therapeutics
HOWL
$22.4M
| $26.2K | ﹤0.01% |
13,275
+39
| +0.3% | +$53 |
|
4788
Trump Media & Technology Group
DJT
$2.73B
| $26K | ﹤0.01% |
1,581
-38,337
| -96% | -$680K |
|
4789
Vanguard Financials ETF
VFH
$13.4B
| $25.7K | ﹤0.01% |
196
-64
| -25% | -$8.29K |
|
4790
Takeda Pharmaceutical
TAK
$56.7B
| $25.6K | ﹤0.01% |
1,749
+172
| +11% | +$2.55K |
|
4791
Caesarstone
CSTE
$69.5M
| $25.3K | ﹤0.01% |
15,932
-3,106
| -16% | -$5.06K |
|
4792
Innovator US Equity Buffer ETF August
BAUG
$198M
| $25.3K | ﹤0.01% |
516
-3,090
| -86% | -$147K |
|
4793
Zai Lab
ZLAB
$2.07B
| $24.9K | ﹤0.01% |
735
-6,803
| -90% | -$234K |
|
4794
CALL
Duke Energy
DUK
$101B
| $24.8K | ﹤0.01% |
+200
| New | +$24.3K |
|
4795
CALL
Steris
STE
$22.9B
| $24.7K | ﹤0.01% |
+100
| New | +$23.9K |
|
4796
CALL
Cboe Global Markets
CBOE
$32.2B
| $24.5K | ﹤0.01% |
+100
| New | +$24K |
|
4797
Taylor Devices
TAYD
$176M
| $24K | ﹤0.01% |
490
+489
| +48,900% | +$22.7K |
|
|
CGC
4798
Canopy Growth
CGC
$376M
| $23.7K | ﹤0.01% |
16,203
-2,800
| -15% | -$3.64K |
|
4799
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$300M
| $23.6K | ﹤0.01% |
700
| – | – |
|
4800
Navios Maritime Partners
NMM
$2.22B
| $22.4K | ﹤0.01% |
497
+201
| +68% | +$8.9K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.